Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs modified cocktail local infiltration after anal fistula surgery
ChiCTR2600116519Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine and ropivacaine in anal fistula (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Pain intensity (NRS score) and Rescue analgesic use. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
anal fistula
Beyond the preview
Go deeper on ChiCTR2600116519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116519.